Investment Analysts’ Weekly Ratings Changes for Bath & Body Works (BBWI)

Bath & Body Works (NYSE: BBWI) recently received a number of ratings updates from brokerages and research firms:

• 2/25/2025 – Bath & Body Works had its “outperform” rating reaffirmed by analysts at Raymond James. They now have a $46.00 price target on the stock, up previously from $42.00.
• 2/24/2025 – Bath & Body Works was upgraded by analysts at Barclays PLC from an “underweight” rating to an “equal weight” rating. They now have a $43.00 price target on the stock, up previously from $34.00.
• 2/20/2025 – Bath & Body Works had its “outperform” rating reaffirmed by analysts at Telsey Advisory Group. They now have a $43.00 price target on the stock.
• 2/18/2025 – Bath & Body Works was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $47.00 price target on the stock, up previously from $41.00.
• 1/24/2025 – Bath & Body Works had its price target raised by analysts at JPMorgan Chase & Co. from $39.00 to $41.00. They now have a “neutral” rating on the stock.
• 1/10/2025 – Bath & Body Works was upgraded by analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating. They now have a $48.00 price target on the stock, up previously from $42.00.
• 1/10/2025 – Bath & Body Works had its “hold” rating reaffirmed by analysts at Argus.
• 1/6/2025 – Bath & Body Works had its price target raised by analysts at Piper Sandler from $36.00 to $39.00. They now have a “neutral” rating on the stock.

Bath & Body Works Trading Up 2.5 %

NYSE:BBWI traded up $1.03 during midday trading on Wednesday, hitting $41.66. 921,624 shares of the company were exchanged, compared to its average volume of 3,303,362. Bath & Body Works, Inc. has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The company has a market capitalization of $9.02 billion, a PE ratio of 10.16, a price-to-earnings-growth ratio of 0.92 and a beta of 1.83. The company has a fifty day simple moving average of $37.77 and a 200 day simple moving average of $34.02.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.46 by $0.03. The business had revenue of $1.61 billion for the quarter, compared to analysts’ expectations of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business’s revenue was up 3.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.48 earnings per share. As a group, equities research analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 7th. Stockholders of record on Friday, February 21st will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.92%. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.51%.

Institutional Trading of Bath & Body Works

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Golden State Wealth Management LLC purchased a new position in Bath & Body Works in the 4th quarter valued at $26,000. SRS Capital Advisors Inc. grew its position in Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock worth $26,000 after buying an additional 329 shares during the period. True Wealth Design LLC increased its holdings in Bath & Body Works by 5,270.0% in the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after buying an additional 1,054 shares in the last quarter. UMB Bank n.a. lifted its position in shares of Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after acquiring an additional 335 shares during the period. Finally, Lindbrook Capital LLC boosted its stake in shares of Bath & Body Works by 81.9% during the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock worth $37,000 after acquiring an additional 431 shares in the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.